Marta Kubera Selected Research

Inflammation (Inflammations)

1/2018	Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures.
1/2016	Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.
10/2015	Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction is connected with their suppressive effect on NKT and CD8(+) T cells but not on TCR delta T cells.
11/2014	The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins.
5/2014	Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
9/2013	In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
1/2013	Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.
1/2013	Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs.
2/2012	Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
2/2012	Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Kubera Research Topics

Disease

15	Inflammation (Inflammations) 01/2018 - 12/2007
13	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022 - 08/2007
12	Fatigue 01/2022 - 08/2007
7	Neoplasms (Cancer) 01/2023 - 11/2009
6	Schizophrenia (Dementia Praecox) 02/2020 - 11/2003
5	Depressive Disorder (Melancholia) 02/2020 - 11/2009
5	Contact Dermatitis (Eczema, Contact) 01/2017 - 01/2012
5	Neuroblastoma 11/2009 - 04/2004
5	Treatment-Resistant Depressive Disorder 11/2009 - 02/2004
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2009
4	Infections 01/2022 - 08/2007
4	Mood Disorders (Mood Disorder) 01/2022 - 01/2013
4	Melanoma (Melanoma, Malignant) 01/2013 - 11/2009
3	Wounds and Injuries (Trauma) 01/2022 - 12/2010
3	Insulin Resistance 01/2022 - 01/2013
3	Psychotic Disorders (Schizoaffective Disorder) 02/2020 - 11/2002
3	Anhedonia 07/2017 - 07/2013
3	Medically Unexplained Symptoms 09/2013 - 02/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 01/2009
3	Seizures (Absence Seizure) 09/2007 - 11/2003
2	Bipolar Disorder (Manic Depressive Psychosis) 02/2020 - 02/2020
2	Obesity 03/2018 - 01/2011
2	Brain Diseases (Brain Disorder) 01/2017 - 01/2011
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 02/2012 - 01/2011
2	Mental Disorders (Mental Disorder) 01/2010 - 01/2007
2	Heart Failure 01/2009 - 01/2009
2	Cocaine-Related Disorders (Cocaine Addiction) 08/2008 - 01/2004
2	Pain (Aches) 07/2008 - 08/2007
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	COVID-19 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 02/2020

Drug/Important Bio-Agent (IBA)

19	Antidepressive Agents (Antidepressants)IBA 01/2023 - 02/2004
8	Fluoxetine (Prozac)FDA LinkGeneric 01/2023 - 02/2004
8	CytokinesIBA 01/2023 - 11/2009
7	Desipramine (Pertofrane)FDA LinkGeneric 01/2023 - 11/2009
7	Immunoglobulin M (IgM)IBA 02/2020 - 02/2008
5	Tryptophan (L-Tryptophan)FDA Link 02/2020 - 12/2007
5	Interleukin-10 (Interleukin 10)IBA 02/2020 - 12/2011
5	Immunoglobulin A (IgA)IBA 02/2020 - 02/2008
5	GlucocorticoidsIBA 03/2018 - 01/2007
5	AntibodiesIBA 09/2013 - 01/2010
5	AntioxidantsIBA 04/2011 - 06/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2011
4	CorticosteroneIBA 03/2014 - 07/2008
4	NeopterinIBA 02/2012 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
3	EpitopesIBA 02/2020 - 02/2012
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2018 - 12/2004
3	Sucrose (Saccharose)IBA 07/2017 - 07/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2013
3	HaptensIBA 10/2015 - 01/2013
3	AntigensIBA 10/2015 - 01/2013
3	InterferonsIBA 03/2014 - 01/2011
3	LipopolysaccharidesIBA 02/2012 - 02/2004
3	Antipsychotic Agents (Antipsychotics)IBA 01/2011 - 11/2002
3	EnzymesIBA 12/2010 - 12/2007
3	StaurosporineIBA 11/2009 - 07/2007
3	Cocaine (Cocaine HCl)IBA 08/2008 - 11/2003
2	Mirtazapine (Rexer)FDA LinkGeneric 01/2023 - 01/2013
2	InterleukinsIBA 01/2022 - 04/2011
2	ChemokinesIBA 02/2020 - 01/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2020 - 01/2016
2	KynurenineIBA 08/2019 - 12/2007
2	Kynurenic Acid (Kynurenate)IBA 01/2018 - 12/2007
2	Serotonin (5 Hydroxytryptamine)IBA 09/2013 - 02/2012
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 11/2009
2	MitogensIBA 01/2013 - 06/2004
2	Interleukin-1 (Interleukin 1)IBA 02/2012 - 02/2012
2	Muramidase (Lysozyme)IBA 02/2012 - 02/2012
2	Phosphotransferases (Kinase)IBA 04/2011 - 11/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2011 - 03/2005
2	PeroxidesIBA 04/2011 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 11/2009
2	Amantadine (Aman)FDA LinkGeneric 11/2009 - 11/2009
2	coenzyme Q10 (CoQ10)IBA 01/2009 - 01/2009
2	NeurosteroidsIBA 09/2008 - 11/2003
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2008 - 11/2006
2	Dehydroepiandrosterone SulfateIBA 09/2008 - 11/2003
2	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 07/2007 - 11/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	CateninsIBA 01/2022
1	CalciumIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2020
1	Complement System Proteins (Complement)IBA 02/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2020
1	Interleukin-4 (Interleukin 4)IBA 02/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	HaptoglobinsIBA 02/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2020

Therapy/Procedure

2	Injections 01/2023 - 07/2013
2	Therapeutics 01/2018 - 01/2004